Introduction {#S5}
============

The ever-increasing obesity epidemic and related comorbidities such as Type II diabetes and heart disease are pushing obese individuals to undergo dieting through caloric restriction. Unfortunately, many of them fail to continue dieting because the initial weight loss induces a strong drive of hunger and decreased energy expenditure as counter-regulatory responses for the body to restore its lost weight. The sense of hunger during starvation or caloric restriction is thought to be primarily mediated by a specific neuronal population in the mediobasal hypothalamus (MBH) through increased expression of orexigenic 'appetite-stimulating' neuropeptides, agouti-related protein (AgRP) and neuropeptide Y (NPY)^[@R1],\ [@R2]^. In this regard, the surprising absence of associated hunger drive in spite of a significant amount of weight loss following Roux-en-Y gastric bypass (RYGB) surgery^[@R3]--[@R5]^ strongly points to possible alterations in the expression of these critical neuropeptides. Others have previously investigated changes in hypothalamic gene expressions of several neuropeptides and hormone receptors following RYGB surgery, but the findings are not consistent. Vrang group^[@R6]^ showed that RYGB surgery paradoxically increased mRNA of NPY and AgRP in the arcuate nucleus compared to sham-operated rats 8 weeks post-operatively, whereas others demonstrated no changes in POMC (proopiomelanocortin)/CART (cocaine/amphetamine-regulated transcript) or NPY/AgRP^[@R7],\ [@R8]^, or decreased hypothalamic NPY mRNA 3--8 weeks post-operatively^[@R9]^. More importantly, none of these studies included a weight-matched calorie-restricted group that is critical for dissecting the effect of weight loss independent of RYGB surgery.

We have recently developed a mouse model of RYGB surgery whose body weight and composition changes mirror those seen in humans with low mortality and complication rates^[@R10]^. The aim of the study was to utilize this mouse model, with addition of the important weight-matched group, to conduct a comprehensive mRNA analysis of key genes in the MBH involved in the regulation of appetite, body weight, inflammation, and oxidative stress at two time points -- at 2 weeks post-surgery during the rapid weight loss phase, and at 12 weeks post-surgery when body weight has stabilized at a lower level.

Materials and Methods {#S6}
=====================

Animals {#S7}
-------

Male diet-induced obese C57BL6J mice were purchased from Jackson Laboratories at the age of 18 weeks. Upon arrival at the Pennington Biomedical Research Center, they were continued on the same high-fat diet (60% fat; 5.21 kcal/g; Research Diets D12492) and also given access to regular chow (13% fat; 3.36 kcal/g; Purina 5001) for a total of 14 weeks. Animals were kept under standard laboratory conditions with a room temperature of 21--23°C and a 12 h light-dark cycle (lights on at 07:00), with exceptions detailed below. Animal care and experimentation was approved by the Pennington Biomedical Research Center Institutional Animal Care and Use Committee and strictly followed rules and guidelines provided by the American Physiological Society and NIH.

Experimental overview {#S8}
---------------------

DIO mice were randomly stratified into 2 cohorts (2 and 12 week survival after surgery), each with 3 treatment groups with matching average body weight and fat mass \[2 weeks: RYGB, n = 13; sham-surgery (sham, n = 10); no-surgery weight-matched controls (WM, n = 8); 12 weeks: RYGB, n = 9; sham-surgery (sham, n = 10); no-surgery weight-matched controls (WM, n = 8)\]. All 6 groups were fed a two-choice diet consisting of high-fat and regular chow pellets for the duration of the study. While WM mice were given 65% of total caloric intake of RYGB mice in order for them to lose the equivalent amount of weight, 93% of the calories came from HF diet and 7% from regular chow diet, based on the food preference data we observed previously from RYGB mice^[@R10]^. In addition, age-matched control groups (2 weeks: Chow, n = 6; 12 weeks, n = 4) were fed only regular chow and were not subjected to any surgery. Sample size was estimated and chosen based on the previous phenotypic analysis^[@R10]^. Except for the time in the metabolic chambers, no other tests and invasive procedures were conducted that could perturb normal body weight regulation. At the end of the observation period, blood plasma and a large number of tissues were harvested for biochemical and histological analyses. Brains were extracted and immediately frozen with liquid nitrogen and stored at −80°C. Body weight, body composition, food intake, food choice, energy expenditure, and plasma levels of glucose, insulin, and leptin were reported previously^[@R10]^.

RYGB surgery {#S9}
------------

A detailed description of our mouse RYGB surgery can be found elsewhere^[@R11]^. Briefly, a 5--6 cm long Roux limb and a 6--7 cm long biliopancreatic limb were created by cutting the jejunum near the ligament of Treitz and anastomosing the distal end of the cut jejunum to a small gastric pouch and the proximal end with the mid-jejunum. Great care was taken to preserve gastric vessels and nerves near the cardia. Sham surgery consisted of midline laparotomy and gentle mobilization of stomach and intestines.

Real-time (RT) quantitative PCR {#S10}
-------------------------------

Animals were killed at the end of either 2 or 12 weeks after treatments. On the day of sacrifice, food was removed from all cages at 6am and mice were sacrificed between 10am-12pm, resulting in 5 hours of fasting on average. Their brains were harvested, frozen immediately, and stored at −80°C. After sectioning the frozen brains in 200μm with a cryostat, the MBH comprising the arcuate nucleus and the ventromedial nucleus was dissected with micro-punch tools according to the mouse brain atlas^[@R12]^ and preserved in RNAlater (Thermo Fisher Scientific, Waltham, MA). The MBH punches were disrupted and homogenized in Qiagen lysis buffer using a sonicator (Qsonica, Newton, CT). Total RNA was extracted and purified using RNeasy Plus Universal Mini Kit (Qiagen, Germantown, MD) and the quality and quantity of RNA were measured using CYTATION 3 imaging reader (BioTek, Winooski, VT). cDNA was generated from 1μg total RNA using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA) with the following reaction protocol in a thermal cycler (Mastercycler by Eppendorf, Hauppuage, NY): 25°C for 10 minutes, 37°C for 120 minutes, 85°C for 5 minutes. The cDNA was diluted 1:20 with nuclease-free water and stored at −20°C. All primers were designed using the OligoArchitect primer design software and synthesized by Sigma Aldrich (St. Louis, MO). Both no-RT and no-cDNA template negative controls showed absence of homo/hetero-primer dimers and non-specific products at post-amplification. cDNA, at a final concentration of 5 ng/μl, was amplified using iTaq Universal SYBR green Supermix (Biorad, Hercules, CA) on a CFX-Connect real-time PCR instrument (Biorad, Hercules, CA). Standard curves were prepared using serial dilutions of test cDNA at a primer-pair concentration of 450nM and the qPCR efficiency was confirmed for each primer pair. Amplification protocol for all genes was as follows: Initial denaturing at 95°C for 2 minutes followed by 40 cycles of denaturation at 95°C for 5 seconds, annealing at 60°C for 30 seconds, and completed with 95°C for 5 seconds, 65°C for 5 seconds and 95°C for 5 seconds. Melting curve analysis showed a single product for each primer pair. Ct values were determined using the regression fit module from CFX-Connect and final relative quantification was done using the delta-delta Ct method with *Gapdh* as the reference gene. Major neuropeptides (POMC, CART, BDNF, NPY, AgRP) and hormone receptors (ObRb, Y2R, GLP-1R, GHSR) important in appetite and body weight regulation, as well as markers for inflammation or oxidative stress (GFAP, NFkB, RAGE, TNF-α, IL-6, IL-1β, IBA-1, ALCAM), were evaluated through RT-qPCR.

Primer sequences used are as follows: *POMC* -- forward, AAGAGGTTAAGAGCAGTGA; reverse, ACATCTATGGAGGTCTGAAG; *CART* -- forward, GCAAGAAGTCCTGAAGAAG; reverse, GTAAAGACCGTGTGTAAGATT; *NPY* -- forward, CTAGGTAACAAGCGAATGG; reverse, GGTGATGAGATTGATGTAGTG; *AgRP* -- forward, ACAAGAGACCAGGACATC; reverse, CAACAGCAGAACACAACT; *GLP-1R (glucagon-like peptide 1 receptor)* -- forward, TGGCTACATAAGGACAACT; reverse, CAACAAGGATGGCTGAAG; *Y2R* (*peptide YY receptor*) -- forward, GCAGAGGCAGATGAGAAT; reverse, AAGATGATGGAGCAGTAGG; *BDNF (brain-derived neurotrophic factor)* -- forward, TTGGAAGCCTGAATGAATG; reverse, CCTAAGATGAAGCGATTGTT; *ObRb* -- forward, AGTCACAAGATAATGGAGAATAAG; reverse, GGCTCTACTGGAATGGAA; *GHSR* -- forward, GAGCGTCTTCTTCTTCCT; reverse, AGCATCTTCACTGTCTGTT; *TNF-α* -- forward, CCACCATCAAGGACTCAA; reverse, ATCTTATCCAGCCTCATTCT; *IL-6* -- forward, ACAGAAGGAGTGGCTAAG; reverse, AGAGAACAACATAAGTCAGATAC; *IL-1β* -- forward, GCAGCACATCAACAAGAG; reverse, CAGCAGGTTATCATCATCATC; *NF-kB* -- forward, AAGAAGGACACGACAGAA; reverse, CAGGCTATTGCTCATCAC; *GFAP* -- forward, CGCATCACCATTCCTGTA; reverse, GGAGCACGCATCTATCTAA; *RAGE* -- forward, CTACCGAGTCCGAGTCTA; reverse, CCTGGTCTCTTCCTTCAC; *ALCAM* -- forward, GAGGCAGACGATATAAGTGA; reverse, GAGGAGACCAACGACAAT; *IBA-1* -- forward, TCTGCCATCTTGAGAATGA; reverse, TGACATCCACCTCCAATC.

Statistical analysis {#S11}
--------------------

Experimenters were blind to the groups during data analysis. mRNA abundance between 4 groups was first normalized to GAPDH and expressed as fold change from the chow-fed lean control group. This was analyzed by ANOVA followed by Bonferroni's *post hoc* multiple comparison tests. Body weight and caloric intake data were analyzed by repeated ANOVA followed by Bonferroni's *post hoc* multiple comparison tests. Data are presented as Mean ± SEM. Statistically significant difference was set at p\<0.05.

Results {#S12}
=======

Effects on body weight, body composition, and food intake {#S13}
---------------------------------------------------------

The effects on comprehensive metabolic parameters from the 12-week cohort were reported previously^[@R10]^. In this cohort, RYGB reduced body weight by about 17% compared to pre-surgical levels and 34% compared to sham-operated mice, mostly owing to fat mass loss. There was a small mean weight regain of 5% from the nadir that occurred at about 3 weeks. In the 2-week cohort, RYGB reduced body weight by about 22% compared to pre-surgical levels and 18% compared to sham-operated mice ([Supplemental Fig. S1](#SD1){ref-type="supplementary-material"}). Plasma leptin levels at both 2 and 12 weeks of both RYGB and WM mice were much lower than sham mice and not significantly different from chow-fed control mice and from each other^[@R10]^. Food intake was significantly lower for the first 8 days after RYGB, and then recovered to near pre-surgical levels after 2 weeks ([Supplemental Fig. S2](#SD1){ref-type="supplementary-material"}).

Effects on gene expression toward the end of the weight loss phase {#S14}
------------------------------------------------------------------

At 2 weeks, mRNA expression of AgRP and NPY were significantly higher in calorie-restricted but not in mice with RYGB, compared to sham-operated mice ([Fig. 1A](#F1){ref-type="fig"}). There was a similar trend with ghrelin receptor (GHSR) expression that did not reach statistical significance. Compared to chow-fed control mice without any surgery, expression levels of AgRP, NPY, and GHSR were significantly lower in both RYGB and sham-operated mice but not in calorie-restricted WM mice.

Among the anorexigenic genes assessed, only leptin receptor (ObRb) expression was differentially expressed between calorie-restricted and RYGB mice ([Fig. 1A](#F1){ref-type="fig"}). However, somewhat unexpectedly, ObRb expression in calorie-restricted WM mice was significantly higher compared to RYGB mice. There were no significant differences in mRNA expression of the anorexigenic factors POMC and CART among the 4 groups. However, BDNF mRNA was drastically reduced in all 3 groups fed a high-fat diet. Y2R mRNA was significantly lower in the RYGB compared to lean chow-fed controls, while there were no significant differences in GLP-1R expression.

Expression of genes related to inflammation or oxidative stress including TNF-α, RAGE, IL-6, IBA-1, and NFkB ([Fig. 2](#F2){ref-type="fig"}) was generally lowest in mice with RYGB, but not significantly lower than in sham-operated mice. With the exception of TNF-α, none of these genes were upregulated in sham-operated obese mice. The 2.2-fold upregulation of TNF-α was however not statistically significant due to a high variability. Interestingly, RAGE and IBA-1 mRNA was significantly higher in WM group that lost the same amount of weight as RYGB mice.

Effects on gene expression during the weight maintenance phase {#S15}
--------------------------------------------------------------

Most of the differences in the expression of orexigenic genes observed at 2 weeks were no longer observed at 12 weeks, with the exception of NPY, which was significantly lower in sham/obese mice compared to chow-fed controls ([Fig. 1B](#F1){ref-type="fig"}). However, expression of AgRP, NPY, and GHSR was similar between calorie-restricted and RYGB mice.

Among the anorexigenic genes assessed, POMC was significantly increased in sham vs. RYGB and chow controls ([Fig. 1B](#F1){ref-type="fig"}). Also, there was a trend for increased BDNF in all three high-fat fed groups compared to chow controls, opposite to what we observed at 2 weeks.

Similarly, except for IBA-1 and ALCAM, TNF-α, IL-6, IL-1β and NFkB mRNA was no longer upregulated in WM controls ([Fig. 2](#F2){ref-type="fig"}).

Discussion {#S16}
==========

Orexigenic NPY/AgRP and anorexigenic POMC/CART-expressing neurons located in the MBH play a critical role in controlling body weight and food intake as they are able to sense nutrients and related signals such as leptin, insulin, and GLP-1^[@R13]^. Eating to satiety^[@R1],\ [@R14]^ has been shown to stimulate POMC and CART gene expression and inhibit NPY and AgRP expression. Conversely, in a state of nutrient deficit such as mild caloric restriction (30%)^[@R15]^, food deprivation (24-48h)^[@R1],\ [@R14]^ or longer starvation (4-6 days) with significant weight loss^[@R2],\ [@R16]^, NPY and AgRP expression is induced while that of POMC and CART is suppressed. Given that RYGB surgery lowers drive of hunger even after a profound weight loss^[@R3]--[@R5]^, we would predict lower NPY and AgRP mRNA, and perhaps higher expression of POMC and CART. In contrast, their expression is expected to increase during caloric restriction-induced weight loss, indicating greater hunger and craving. Indeed, our results extend the previous findings^[@R6]--[@R9]^ and demonstrate that RYGB induces changes in hypothalamic genes that are distinct from those in caloric-restricted, weight-matched controls, suggesting weight loss-independent effects. More interestingly, many of these RYGB-specific differences disappear during the chronic weight-maintenance phase in spite of the sustained body weight loss.

As expected, mice weight-matched to RYGB by caloric restriction had increased gene expressions of NPY and AgRP compared to sham obese group, suggesting that they were "hungry" and eager to restore their original body weight. Unlike the calorie-restricted WM mice, RYGB mice did not upregulate NPY and AgRP expression, suggesting that they were not "hungry" and willing to restore their pre-surgical body weight. This is supported by their food intake that is near pre-surgical levels but not higher to gain back their lost weight. Kawasaki group has shown similar findings after sleeve gastrectomy in HF-fed rats^[@R17]^. Given that mice with RYGB lose about 1--3 kcal/day of energy in the feces^[@R18],\ [@R19]^, their food intake may not quite be restored at the end of 2 weeks. Thus, weight loss induced by RYGB provoked opposite responses in AgRP and NPY mRNA, consistent with the notion that RYGB surgery establishes a lower body weight set-point. In line with others' findings^[@R20]^, sham-operated, obese mice displayed lower NPY and AgRP mRNA compared to chow-fed lean controls, reflecting a state of positive energy balance. On the other hand, anorexigenic POMC and CART mRNA was not different between groups which is in agreement with findings by Grayson and colleagues^[@R7]^. While the reason is not clear, an earlier study by the Meguid lab^[@R21]^ has shown increased immunostaining of a-MSH, an anorexigenic peptide post-translationally cleaved from POMC, following RYGB surgery. It is thus possible that in our study, RYGB in obese mice raises the melanocortinergic tone, which is not reflected in POMC mRNA, to counter the hunger drive associated with weight loss. This may also explain lower AgRP and NPY mRNA compared to those in WM group. This warrants further investigation.

Reduced Y2R in RYGB mice compared to chow-fed lean controls may be interpreted as a compensatory downregulation due to over-activation of the receptor by the anorexigenic gut hormone PYY. Although not measured in this study, our^[@R22]^ and others' previous work^[@R23]^ clearly demonstrated substantially higher basal and/or meal-stimulated plasma PYY levels after RYGB surgery. This may also help explain lower NPY/AgRP mRNA expression in spite of dramatic weight loss in these mice. The same potential mechanism does not seem to apply for lower ObRb in RYGB mice since their plasma leptin levels were low and comparable to that of both lean and WM control groups.

About half of the genes related to inflammation or oxidative stress were reduced in sham obese mice compared to chow-fed lean controls, although not reaching statistical significance for the most part. While HF feeding or diet-induced obesity is often associated with hypothalamic inflammation^[@R24]^, our data are in agreement with others' findings that showed either no change or even decreased hypothalamic inflammatory markers in diet-induced obese mice^[@R25],\ [@R26]^. The discrepancy may be explained by the duration of HF feeding and/or HF diet composition. Importantly, mRNA of these markers were similarly lowered in RYGB but not WM group, suggesting that WM mice might perceive restricted feeding and the subsequent weight reduction as stressors while RYGB mice do not. It would be critical to consider these data with proteomics and metabolomics analyses, among others, in near future to better understand if RYGB surgery indeed alters hypothalamic inflammatory state.

It is important to mention that while food was removed from all cages 5h before sacrifice, we observed that calorie-restricted WM mice finished their reduced food ration beforehand sometime during the second half of the dark phase, resulting in a fasting duration of about 6--10h rather than 5h as intended. Therefore, this longer fasting duration in WM mice could have potentially contributed to the differences in our gene expression data. However, two important considerations suggest that this difference in fasting duration likely was not responsible for the large observed differences in gene expression. First, AgRP and NPY gene regulation is known to be driven primarily by the overall energy status of an organism (ie. body weight, fat mass) and not by a relatively acute, short-term fasting. In support of this notion, many studies have shown that at least 48h fasting or longer that leads to marked reduction in body weight significantly increases AgRP and/or NPY mRNA^[@R2],\ [@R14],\ [@R16],\ [@R27]--[@R32]^. Boswell and colleagues have shown that 18h fasting was sufficient to induce changes in gene expression^[@R33]^, which is still longer than the potential 10h fasting with WM mice. Only one group has demonstrated that NPY mRNA was significantly increased by over 2-fold after only 4h fasting, but that level came down by 8h fasting^[@R34]^. More convincing evidence comes from a study by Xu and colleagues^[@R35]^ that showed that rats undergoing food restriction without weight loss do not show a significant increase of NPY mRNA up to 16h of fasting, indicating that NPY/AgRP genes do not change much due to a moderate fasting if it does not involve a significant weight loss. Collectively, these studies suggest that NPY/AgRP mRNA is more sensitive to long-term energy status, that is, to a reduction in weight or fat mass, but not to short-term fasting. Second, leptin is an adipocyte-derived hormone whose plasma level is sensitive to short-term fluctuations in nutritional state. This is supported by studies demonstrating a significant drop of plasma leptin only after 4--6h fasting^[@R34],\ [@R36],\ [@R37]^. The fact that plasma leptin levels in RYGB and WM mice in our study were essentially identical at the time of sacrifice (ng/ml±SEM; 4.5±0.7 RYGB vs. 4.8±1.3 WM)^[@R10]^ strongly indicates similar nutritional status between these groups, in other words, a similar fasting state. Thus, although we cannot rule out different fasting durations in WM vs. other groups, we think it is very unlikely that few more hours of fasting in WM mice would have caused the differences in gene expression we observed in this study. Rather, our findings are consistent with the idea that RYGB surgery suppresses the adaptive hunger response.

Sham and RYGB mice show divergent body weight curves during the acute phase while sharing similar mRNA levels for many genes examined here, suggesting that these genes may serve different roles after surgery. Interestingly, most of the changes were no longer present during the chronic phase when RYGB mice were successfully sustaining their weight loss. This may indicate reduced sensitivity to RYGB-induced signaling mechanisms. Alternatively, there may be a group of genes important for "lowering" vs. "maintaining" body weight and fat mass within and/or outside the MBH. Given the reduction of BDNF mRNA among treatment groups in the acute phase and its concerted return to the pre-surgical levels in the chronic phase, we speculate that BDNF may be one of the genes that help maintain new body weight and fat mass.

In conclusion, we provide evidence demonstrating that RYGB surgery differentially regulates hypothalamic genes critical for appetite, body weight, and inflammation/oxidative stress during the acute "rapid weight-loss" phase and chronic "weight maintenance" phase. Importantly, our findings show that weight loss induced by caloric restriction but not RYGB increases the expression of orexigenic and inflammatory genes, suggesting that RYGB surgery suppresses the adaptive hunger and stress response to weight loss. Our results further show that these changes disappear during the weight-maintenance / weight-regain phase, possibly indicating development of tolerance to the RYGB-induced signaling mechanisms.
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![Effects of RYGB surgery on mRNA abundance of orexigenic and anorexigenic genes in the MBH.\
One cohort was sacrificed at 2 weeks (acute; Sham n=10; RYGB n=13; WM n=8; Chow n=6) and the other at 12 weeks (chronic; Sham n=10; RYGB n=9; WM n=8; Chow n=4) post-surgically. Expression of oregixenic genes and anorexigenic genes during **A)** acute "weight-loss" phase and **B)** chronic "weight-maintenance" phase. mRNA levels are first normalized to GAPDH and are expressed as fold change from the chow-fed lean control group. Per each gene, bars without letters are not different from each other, while bars that do not share the same letters are statistically significant from each other. Data are presented as Mean±SEM. p\<0.05 based on one-way ANOVA followed by Bonferroni post-hoc test.](nihms-1517563-f0001){#F1}

![Effects of RYGB surgery on mRNA abundance of genes in the MBH involved in inflammation and/or oxidative stress at 2 or 12 weeks post-surgery.\
Per each gene, bars without letters are not different from each other, while bars that do not share the same letters are statistically significant from each other. Data are presented as Mean±SEM. p\<0.05 based on one-way ANOVA followed by Bonferroni post-hoc test.](nihms-1517563-f0002){#F2}
